Premier, Inc. (PINC)
USD 19.02
(-2.19%)
USD 19.02
(-2.19%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 286.08 Million USD | -35.48% |
| 2023 | 398.26 Million USD | -1.19% |
| 2022 | 467.14 Million USD | -1.94% |
| 2021 | 383.66 Million USD | -21.22% |
| 2020 | 547.82 Million USD | 1.24% |
| 2019 | 508.67 Million USD | -22.94% |
| 2018 | 671.75 Million USD | 200.96% |
| 2017 | 437.74 Million USD | -36.53% |
| 2016 | 350.1 Million USD | 4.01% |
| 2015 | 320.36 Million USD | 10.91% |
| 2014 | 341.87 Million USD | -24.63% |
| 2013 | 401.88 Million USD | 15.88% |
| 2012 | 347.48 Million USD | 5.41% |
| 2011 | 328.85 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | -28.17% |
| 2024 Q3 | -44.86 Million USD | -130.76% |
| 2024 Q2 | 98.47 Million USD | 10.19% |
| 2024 Q4 | 133.08 Million USD | 471.35% |
| 2024 Q1 | 91.98 Million USD | 27.32% |
| 2023 Q2 | 127.25 Million USD | 29.22% |
| 2023 Q1 | 98.47 Million USD | 15.56% |
| 2023 Q4 | 70.18 Million USD | -31.42% |
| 2023 Q3 | 102.34 Million USD | -19.58% |
| 2023 FY | - USD | -1.19% |
| 2022 Q4 | 85.21 Million USD | 25.84% |
| 2022 FY | - USD | -1.94% |
| 2022 Q1 | 110.5 Million USD | 35.61% |
| 2022 Q2 | 118.19 Million USD | 6.96% |
| 2022 Q3 | 67.71 Million USD | -42.71% |
| 2021 FY | - USD | -21.22% |
| 2021 Q2 | 113.86 Million USD | 27.12% |
| 2021 Q4 | 81.48 Million USD | -19.42% |
| 2021 Q3 | 101.12 Million USD | -11.19% |
| 2021 Q1 | 89.57 Million USD | 2.25% |
| 2020 Q1 | 121.62 Million USD | 15.8% |
| 2020 Q3 | 155.46 Million USD | 21.81% |
| 2020 Q4 | 87.59 Million USD | -43.65% |
| 2020 FY | - USD | 1.24% |
| 2020 Q2 | 127.62 Million USD | 4.93% |
| 2019 Q4 | 105.03 Million USD | -14.18% |
| 2019 Q2 | 134.41 Million USD | 5.96% |
| 2019 Q1 | 126.85 Million USD | -8.52% |
| 2019 FY | - USD | -22.94% |
| 2019 Q3 | 122.38 Million USD | -8.95% |
| 2018 Q4 | 138.66 Million USD | 23.26% |
| 2018 Q3 | 112.49 Million USD | -62.1% |
| 2018 Q2 | 296.81 Million USD | 190.41% |
| 2018 Q1 | 102.2 Million USD | -15.41% |
| 2018 FY | - USD | 200.96% |
| 2017 Q3 | 108.95 Million USD | 203.93% |
| 2017 Q2 | -104.84 Million USD | -207.8% |
| 2017 FY | - USD | -36.53% |
| 2017 Q1 | 97.26 Million USD | 28.4% |
| 2017 Q4 | 120.83 Million USD | 10.89% |
| 2016 Q2 | 91.56 Million USD | 6.24% |
| 2016 Q3 | 96.6 Million USD | 5.51% |
| 2016 Q4 | 75.75 Million USD | -21.59% |
| 2016 FY | - USD | 4.01% |
| 2016 Q1 | 86.18 Million USD | 3.71% |
| 2015 FY | - USD | 10.91% |
| 2015 Q1 | 77.35 Million USD | 23.36% |
| 2015 Q4 | 83.1 Million USD | -1.07% |
| 2015 Q3 | 84 Million USD | 4.91% |
| 2015 Q2 | 80.06 Million USD | 3.51% |
| 2014 Q2 | 71.2 Million USD | -39.78% |
| 2014 Q3 | 41.87 Million USD | -41.19% |
| 2014 Q4 | 62.7 Million USD | 49.75% |
| 2014 Q1 | 118.23 Million USD | 5.25% |
| 2014 FY | - USD | -24.63% |
| 2013 FY | - USD | 15.88% |
| 2013 Q4 | 112.33 Million USD | 4.85% |
| 2013 Q3 | 107.14 Million USD | 17.66% |
| 2013 Q2 | 91.06 Million USD | -0.32% |
| 2013 Q1 | 91.35 Million USD | 0.0% |
| 2012 FY | - USD | 5.41% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 1014.314% |
| Augmedix, Inc. | -17.68 Million USD | 1718.059% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 18.147% |
| CareCloud, Inc. | -31.29 Million USD | 1014.314% |
| HealthEquity, Inc. | 282.41 Million USD | -1.301% |
| iCoreConnect Inc. | -11.87 Million USD | 2508.28% |
| Inovalon Holdings, Inc. | 186.56 Million USD | -53.347% |
| Nutex Health, Inc. | -14.58 Million USD | 2062.019% |
| Omnicell, Inc. | 60.69 Million USD | -371.394% |
| OneMedNet Corporation | -11.97 Million USD | 2489.899% |
| Progyny, Inc. | 64.46 Million USD | -343.79% |
| Renalytix Plc | -28.52 Million USD | 1103.082% |
| Schrödinger, Inc. | -171.89 Million USD | 266.431% |
| Simulations Plus, Inc. | 6.13 Million USD | -4566.27% |
| SOPHiA GENETICS SA | -70.7 Million USD | 504.652% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 2332.28% |
| Ontrak, Inc. | -14.41 Million USD | 2084.524% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 91.964% |
| Sharecare, Inc. | -67.25 Million USD | 525.386% |
| Aclarion, Inc. | -4.14 Million USD | 7009.673% |
| CareMax, Inc. | -590.46 Million USD | 148.452% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 5523.432% |
| Forian Inc. | 2.75 Million USD | -10302.136% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 5523.432% |
| HeartBeam, Inc. | 675 Thousand USD | -42283.556% |
| GeneDx Holdings Corp. | -136.46 Million USD | 309.65% |
| SCWorx Corp. | -3.97 Million USD | 7297.76% |
| Minerva Surgical, Inc. | -20.07 Million USD | 1525.243% |
| Definitive Healthcare Corp. | -241.22 Million USD | 218.597% |
| 10x Genomics, Inc. | -205.11 Million USD | 239.48% |
| Zhongchao Inc. | -4.9 Million USD | 5935.749% |
| Accolade, Inc. | -71.19 Million USD | 501.85% |
| MSP Recovery, Inc. | -69.22 Million USD | 513.298% |
| R1 RCM Inc. | 426.2 Million USD | 32.874% |
| Spok Holdings, Inc. | 26.29 Million USD | -987.915% |
| Privia Health Group, Inc. | 27.18 Million USD | -952.494% |
| EUDA Health Holdings Limited | -8.3 Million USD | 3546.706% |
| TruBridge, Inc. | -15.39 Million USD | 1958.807% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 18.147% |
| Sharecare, Inc. | -67.25 Million USD | 525.386% |
| Health Catalyst, Inc. | -66.46 Million USD | 530.455% |
| GoodRx Holdings, Inc. | 108.82 Million USD | -162.891% |
| HealthStream, Inc. | 59.58 Million USD | -380.12% |
| Certara, Inc. | 23.84 Million USD | -1099.836% |
| GeneDx Holdings Corp. | -136.46 Million USD | 309.65% |
| Ontrak, Inc. | -14.41 Million USD | 2084.524% |
| SHL Telemedicine Ltd. | 3.28 Million USD | -8612.891% |
| CareCloud, Inc. | -31.29 Million USD | 1014.314% |
| EUDA Health Holdings Limited | -8.3 Million USD | 3546.706% |
| HeartBeam, Inc. | 675 Thousand USD | -42283.556% |
| Mangoceuticals, Inc. | -9.18 Million USD | 3213.884% |
| CareMax, Inc. | -590.46 Million USD | 148.452% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 7070.98% |
| National Research Corporation | 45.98 Million USD | -522.135% |
| Aclarion, Inc. | -4.14 Million USD | 7009.673% |
| OptimizeRx Corporation | -21.3 Million USD | 1442.611% |